Aethlon Medical Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Valuation Ratios
P/S Ratio15.3076.4737.34
P/B Ratio1.440.760.581.322.65
Price/Tangible Book1.440.760.581.312.63
Enterprise Value Ratios
EV/Revenue7.8218.83
Profitability & Returns
Return on Equity (ROE)-2.46%-1.17%-0.75%-0.79%-0.85%
Return on Assets (ROA)-0.75%-0.61%-0.40%-0.43%-0.47%
Return on Capital Employed (ROCE)-1.71%-1.97%-0.74%-0.59%-0.85%
Leverage & Solvency Ratios
Debt/Equity0.160.160.080.040.01
Liquidity Ratios
Current Ratio3.133.4010.039.957.53
Quick Ratio2.902.979.669.437.28
Efficiency Ratios
Asset Turnover0.030.020.06
Yield & Distribution Ratios
Earnings Yield-1.81%-2.77%-1.37%-0.46%-0.32%
FCF Yield-1.03%-2.36%-1.30%-0.45%-0.28%
Buyback Yield-3.97%-0.22%-0.39%-0.22%